1. Home
  2. TLS vs VYGR Comparison

TLS vs VYGR Comparison

Compare TLS & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLS
  • VYGR
  • Stock Information
  • Founded
  • TLS 1969
  • VYGR 2013
  • Country
  • TLS United States
  • VYGR United States
  • Employees
  • TLS N/A
  • VYGR N/A
  • Industry
  • TLS EDP Services
  • VYGR Biotechnology: Pharmaceutical Preparations
  • Sector
  • TLS Technology
  • VYGR Health Care
  • Exchange
  • TLS Nasdaq
  • VYGR Nasdaq
  • Market Cap
  • TLS 249.6M
  • VYGR 342.5M
  • IPO Year
  • TLS 2020
  • VYGR 2015
  • Fundamental
  • Price
  • TLS $3.47
  • VYGR $5.91
  • Analyst Decision
  • TLS Buy
  • VYGR Strong Buy
  • Analyst Count
  • TLS 5
  • VYGR 9
  • Target Price
  • TLS $4.50
  • VYGR $16.44
  • AVG Volume (30 Days)
  • TLS 324.5K
  • VYGR 463.2K
  • Earning Date
  • TLS 11-12-2024
  • VYGR 11-12-2024
  • Dividend Yield
  • TLS N/A
  • VYGR N/A
  • EPS Growth
  • TLS N/A
  • VYGR N/A
  • EPS
  • TLS N/A
  • VYGR 0.47
  • Revenue
  • TLS $122,959,000.00
  • VYGR $163,784,000.00
  • Revenue This Year
  • TLS N/A
  • VYGR N/A
  • Revenue Next Year
  • TLS $38.31
  • VYGR N/A
  • P/E Ratio
  • TLS N/A
  • VYGR $12.57
  • Revenue Growth
  • TLS N/A
  • VYGR 3.40
  • 52 Week Low
  • TLS $1.89
  • VYGR $5.19
  • 52 Week High
  • TLS $5.03
  • VYGR $11.72
  • Technical
  • Relative Strength Index (RSI)
  • TLS 48.64
  • VYGR 45.22
  • Support Level
  • TLS $3.26
  • VYGR $5.60
  • Resistance Level
  • TLS $3.91
  • VYGR $6.55
  • Average True Range (ATR)
  • TLS 0.22
  • VYGR 0.33
  • MACD
  • TLS -0.00
  • VYGR -0.04
  • Stochastic Oscillator
  • TLS 33.33
  • VYGR 32.76

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: